Financhill
Back

PROCEPT BioRobotics 10K Form

Buy
81

PRCT
PROCEPT BioRobotics

Last Price:
48.39
Seasonality Move:
26.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $75.01M
Cash Flow: $-24.72M
Price / Cash Flow: 0
Annual Sales: $5.93
Price / Book: 8.33

Profitability

EPS (TTM): -2.33000
Net Income (TTM): $-106.56M
Gross Margin: $37.09M
Return on Equity: -50.93%
Return on Assets: -33.07%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 4 years for PRCT is 49.44%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 118.42% of Gross Profit Margin.
  • The Research & Development expenses have been 38.63% of Revenue.
  • The Interest Expense is -5.95% of Operating Income.
  • The Net Earning history of PRCT is -116.18% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sector: Healthcare
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 8.91
Quick Ratio: 7.78

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Buy
81
PROCEPT BioRobotics (PRCT) is a Buy

Is PROCEPT BioRobotics a Buy or a Sell?